Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/832
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Trandolapril (Tablet)
|
| dailymed-instance:dosage |
Dosage Adjustment in Renal Impairment or Hepatic Cirrhosis:
|
| dailymed-instance:clinicalP... |
Mechanism of Action:<br/>Pharmacokinetics and Metabolism:<br/>Pharmacokinetics:<br/>Metabolism and Excretion:<br/>Special populations:<br/>Pediatric:<br/>Geriatric and Gender:<br/>Race:<br/>Renal Insufficiency:<br/>Hepatic Insufficiency:<br/>Drug Interactions:<br/>Pharmacodynamics and Clinical Effects:
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
Trandolapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.
|
| dailymed-instance:supply |
Manufactured for:Aurobindo Pharma USA, Inc.2400 Route 130 NorthDayton, NJ 08810 Manufactured by:Aurobindo Pharma LimitedHyderabad���500 072, India
|
| dailymed-instance:genericDr... | |
| dailymed-instance:boxedWarn... |
BOXED WARNING:<br/>USE IN PREGNANCY:
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:possibleD... | |
| dailymed-instance:precautio... |
General:<br/>Impaired Renal Function:<br/>Hyperkalemia and potassium-sparing diuretics:<br/>Cough:<br/>Surgery/anesthesia:<br/>Information for Patients:<br/>Angioedema:<br/>Symptomatic Hypotension:<br/>Hyperkalemia:<br/>Nutropenia:<br/>Pregnancy:<br/>Drug Interactions: Agents increasing serum potassium Lithium Other<br/>Carcinogenesis, Mutagenesis, Impairment of Fertility:<br/>Pregnancy: Pregnancy Categories C (first trimester) and D (second and third trimesters):<br/>Nursing Mothers: Radiolabeled trandolapril or its metabolites are secreted in rat milk. Trandolapril should not be administered to nursing mothers.<br/>Pediatric Use: The safety and effectiveness of trandolapril in pediatric patients have not been established.<br/>Geriatric Use: In placebo-controlled studies of trandolapril, 31.1% of patients were 60 years and older, 20.1% were 65 years and older, and 2.3% were 75 years and older. No overall differences in effectiveness or safety were observed between these patients and younger patients. (Greater sensitivity of some older individual patients cannot be ruled out.)
|
| dailymed-instance:genericMe... |
Trandolapril
|
| dailymed-instance:fullName |
Trandolapril (Tablet)
|
| dailymed-instance:adverseRe... |
Clinical Laboratory Test Findings:
|
| dailymed-instance:warning |
Anaphylactoid and Possibly Related Reactions:<br/>Anaphylactoid Reactions During Desensitization:<br/>Anaphylactoid Reactions During Membrane Exposure:<br/>Head and Neck Angioedema:<br/>Intestinal Angioedema:<br/>Hypotension:<br/>Neutropenia/Agranulocytosis:<br/>Hepatic Failure:<br/>Fetal/Neonatal Morbidity and Mortality:
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Trandolapril
|